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Abstract
Background: The nuclear lamina is a key determinant of nuclear architecture, integrity and functionality in metazoan nuclei.
Mutations in the human lamin A gene lead to highly debilitating genetic diseases termed as laminopathies. Expression of
lamin A mutations or reduction in levels of endogenous A-type lamins leads to nuclear defects such as abnormal nuclear
morphology and disorganization of heterochromatin. This is accompanied by increased proteasomal degradation of certain
nuclear proteins such as emerin, nesprin-1a, retinoblastoma protein and heterochromatin protein 1 (HP1). However, the
pathways of proteasomal degradation have not been well characterized.
Methodology/Principal Findings: To investigate the mechanisms underlying the degradation of HP1 proteins upon lamin
misexpression, we analyzed the effects of shRNA-mediated knock-down of lamins A and C in HeLa cells. Cells with reduced
levels of expression of lamins A and C exhibited proteasomal degradation of HP1a and HP1b but not HP1c. Since specific
ubiquitin ligases are upregulated in lamin A/C knock-down cells, further studies were carried out with one of these ligases,
RNF123, which has a putative HP1-binding motif. Ectopic expression of GFP-tagged RNF123 directly resulted in degradation
of HP1a and HP1b. Mutational analysis showed that the canonical HP1-binding pentapeptide motif PXVXL in the N-terminus
of RNF123 was required for binding to HP1 proteins and targeting them for degradation. The role of endogenous RNF123 in
the degradation of HP1 isoforms was confirmed by RNF123 RNAi experiments. Furthermore, FRAP analysis suggested that
HP1b was displaced from chromatin in laminopathic cells.
Conclusions/Significance: Our data support a role for RNF123 ubiquitin ligase in the degradation of HP1a and HP1b upon
lamin A/C knock-down. Hence lamin misexpression can cause degradation of mislocalized proteins involved in key nuclear
processes by induction of specific components of the ubiquitin-proteasome system.
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Introduction
Lamins are intermediate filament proteins that form a
filamentous network underlying the inner nuclear membrane
termed the nuclear lamina. Most of the higher vertebrates contain
two types of lamins, classified primarily on basis of expression
patterns and biochemical properties: A-type and B-type lamins.
The A-type lamins (A and C) are alternatively spliced products of
the lamin A gene that are expressed in differentiated cells, whereas
the B-type lamins (B1 and B2) are encoded by two separate genes
and are expressed in all somatic cells. Lamins play important roles
in the organization of nuclear functions such as DNA replication
and transcription, as well as in chromatin organization and gene
regulation. Mutations in the human lamin A gene (LMNA) lead to
at least 15 debilitating genetic diseases, collectively referred to as
laminopathies. These include muscular dystrophies, cardiomyo-
pathies, lipodystrophies and progerias [1–5].
At the cellular level, mutations in lamin A/C or decrease in
lamin A/C levels cause abnormal nuclear morphology and loss in
heterochromatic markers, which are accompanied by impaired
nuclear function. Downregulation of the single lamin gene of C.
elegans causes abnormal heterochromatin organization leading to
embryonic lethality [6], while misexpression or reduction of
Drosophila A-type lamin results in disruption of heterochromatin
protein 1 (HP1) localization [7]. Similarly, fragmentation of
heterochromatin has been observed in cardiomyocytes derived
from lmna2/2 mice [8]. Furthermore, heterochromatin markers
such as trimethylated Lys-9 of histone H3 (H3K9me3), HP1a and
trimethylated Lys-27 of histone H3 (H3K27me3) are down-
regulated in cells from Hutchinson-Gilford progeria (HGPS)
patients [9–11]. Similarly, cells derived from mandibuloacral
dysplasia type A (MAD-A) patients exhibit reduction of peripheral
heterochromatin, and mislocalization of HP1b, H3K9me3 and
lamin B receptor [12]. Defects in laminopathic cells have been
attributed to impaired gene expression, lamina misassembly,
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altered protein-protein interactions and enhanced proteasomal
degradation [1–5,13]. Lamin A/C misexpression leads to
proteasomal degradation of specific proteins including the
retinoblastoma protein (pRb), emerin, nesprin-1a and HP1 [14–
17]. However, the pathways of proteasomal degradation that are
involved are not well understood.
We have earlier shown that expression of laminopathic mutants
in HeLa cells leads to proteasomal degradation of specific HP1
isoforms, HP1a and HP1b but not HP1c, and this is mediated by
the F-box substrate adapter protein FBXW10 [17]. HP1a and b
are enriched in pericentric heterochromatin and telomeric
heterochromatin whereas HP1c is found in both euchromatin
and heterochromatin [18,19]. Furthermore, we have recently
identified three distinct E3 ubiquitin ligase components that are
upregulated in lamin A/C knock-down HeLa cells, namely RING
finger ubiquitin ligase RNF123, ubiquitin ligase HECW2 and F-
box protein FBXW10 [20]. In this study, we have explored the
mechanisms underlying the depletion of HP1 isoforms by RNF123
upon lamin A/C knock-down. Our expression analysis, RNAi and
binding data suggest that RNF123 mediates the degradation of
HP1a and HP1b by directly binding to HP1 through a canonical
HP1-binding motif.
Results
Downregulation of Endogenous Lamin A/C Leads to
Depletion of HP1a and b
In order to investigate the effects of reduced expression of lamin
A/C on HP1 stability, we employed a vector-based shRNA system
to knock down endogenous lamin A/C levels as described in
Materials and methods. In initial transient transfection experi-
ments, HeLa cells expressing lamin A/C shRNAs and co-
expressing GFP were observed to be depleted in HP1a and b
but not HP1c, whereas cells transfected with control shRNA
vector did not show any effects on HP1 levels (Fig. 1A).
Subsequent experiments were carried out with HeLa cells stably
expressing shRNA against lamin A/C transcripts. In one clone
that has been described earlier (cl27) [20], there was ,90%
reduction in lamin A/C protein by western blot analysis and
nearly complete loss of HP1a and b proteins with no detectable
effects on the levels of HP1c (shown in Fig. 1B). Although the
inner nuclear membrane protein emerin is redistributed in cells
expressing laminopathic mutants that disrupt the lamina [17], it
was not significantly mislocalized to the cytoplasm upon lamin A/
C knock-down, suggesting that the small amount of lamin A/C
that remains at the nuclear rim in these cells is sufficient for the
proper localization of emerin. A previous study has also reported
the normal distribution of emerin in lamin A/C depleted cells
[21].
In order to determine whether reduction of HP1 a and b was
regulated at the protein or transcript level, HP1 transcripts were
quantitated by real-time PCR analysis. This data indicated that
there were no significant changes in HP1 transcript levels (Table 1),
suggesting that lamin A/C knock-down led to degradation of
HP1a and b proteins. We further investigated the expression levels
of genes bound by HP1 proteins to determine whether there were
any changes in expression due to depletion of HP1 isoforms in the
lamin A/C knock-down clones. A previous study has identified a
large gene family of Kruppel associated box-containing zinc finger
(KRAB-ZNF) transcriptional repressors that are the major targets
bound by HP1b [22]. To ascertain the effects of depletion of HP1
proteins, the transcriptional status of a few of the ZNF genes
located on human chromosome 19 namely, ZNF44, ZNF77,
ZNF85, ZNF226 and ZNF266 was determined by real-time PCR
analysis of the two clones of HeLa cells stably expressing lamin A/
C shRNA. A 2-fold upregulation of ZNF44, ZNF77 and ZNF85
transcripts was observed, but the levels of ZNF226 and ZNF266
were only slightly higher (Table 1). Thus depletion of HP1 proteins
in lamin A/C knock-down cells leads to increase in transcripts of
certain KRAB-ZNF genes which are normally repressed by HP1b.
RNF123 Mediates HP1 Degradation in Lamin A/C
Knockdown Cells
Our earlier studies have shown that RING finger ubiquitin
ligase RNF123, HECT-domain ligase HECW2 and the F-box
protein FBXW10 are upregulated in HeLa cells expressing
laminopathic mutants or lamin A/C shRNA [20]. Further studies
have been carried out with RNF123 ubiquitin ligase as it bears a
consensus motif for binding to HP1 proteins, as described below.
RNF123 is a member of the RING family of ligases, one of the
largest enzyme families in the human genome that is represented
by more than 600 genes [23]. RNF123 (also called KPC1 which
stands for Kip1 ubiquitination promoting complex) has previously
been shown to degrade cyclin-dependent kinase inhibitor p27Kip1
[24]. To examine the role of RNF123 in the stability of HP1, we
immunostained HeLa cells ectopically expressing GFP-tagged
RNF123 construct with HP1 antibodies. Overexpression of
RNF123 caused depletion of HP1a and b, but HP1c and lamin
A/C were not affected (Fig. 2A). Expression of GFP-tagged
RNF123 also caused dispersal of emerin into the cytoplasm, as
observed earlier upon expression of FBXW10 or laminopathic
mutants [17], though emerin levels were not altered. To confirm
the role of RNF123 in proteasome-mediated degradation of these
proteins, cells expressing GFP-tagged RNF123 were treated with
the proteasomal inhibitor MG132. It was observed that protea-
somal inhibition by MG132 led to significant restoration of HP1a
and b levels as well as emerin relocation to the nuclear periphery
(Fig. 2B). Western blot analysis of these samples is shown in Fig. 3.
These results indicate that RNF123 ubiquitin ligase mediates the
proteasomal degradation of HP1a and b and possibly another
protein(s) that is required for the proper localization of emerin.
Similar results were obtained with mouse NIH 3T3 cells (data not
shown).
A Canonical HP1 Binding Sequence is Essential for
RNF123 Activity
In order to analyze the binding interactions between HP1
proteins and RNF123, we initially created a series of GFP-tagged
deletion constructs of RNF123 that lacked specific functional
domains. RNF123 has an N-terminal SPRY domain that binds to
an associated subunit termed KPC2 and a C-terminal catalytic
RING finger domain. The p27-binding region of RNF123 spans
beyond its N-terminal SPRY domain and extends towards its C-
terminus [25]. The construct DN-RNF123 (523–1314 amino acid
residues) has a deletion of the SPRY domain and putative
substrate binding segment, while the construct DC-RNF123 (1–
1041 amino acid residues) lacks the RING finger domain.
Individual constructs having either SPRY and substrate binding
domains (N-RNF123) or only the RING finger domain (C-
RNF123) spanning 1–522 and 1042–1314 amino acid residues
respectively, were also generated. GFP-tagged full length RNF123
or its deletion constructs were expressed in HeLa cells. The
immunofluorescence analysis revealed that deletion of either the
SPRY and substrate-binding region or the RING finger domain
rendered the molecule ineffective in degrading HP1a (Fig. 3A),
indicating that both the substrate-specifying N-terminus and the
catalytic RING finger domain are essential for the degradation of
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HP1 proteins. This was substantiated by western blot analysis with
antibodies to HP1 isoforms (Fig. 3C). The expression levels of the
constructs were determined by western blot analysis with anti-GFP
antibody. The subcellular location of all the deletion constructs
was cytoplasmic, as seen with full length RNF123 (Fig. 3A).
The RNF123 motif that binds to HP1 was characterized as
follows. Sequence analysis of RNF123 indicated the presence of
a canonical HP1 binding sequence PXVXL (X= any amino
acid) at position 311–315, downstream of the SPRY domain.
This pentapeptide motif is present in many HP1 interacting
proteins and non-homologous mutations in this binding motif
abolish the protein binding ability of HP1 [26,27]. The
functionality of the HP1 binding motif in RNF123 was
determined by mutating the Val residue of PTVLL in
RNF123 to Asp residue (V313D). Ectopically expressed GFP-
tagged mutant RNF123 was observed to ineffective in depletion
of HP1 isoforms as compared to wild-type full length RNF123
by immunofluorescence and western blot analysis, suggesting
that the PTVLL pentapeptide motif was involved in recruitment
of HP1 proteins to RNF123 followed by their subsequent
degradation (Fig. 3B,C). However, this mutation did not reduce
the overall catalytic activity of RNF123 as emerin was still
dispersed in the cytoplasm in presence of the HP1-binding
Figure 1. Effect of downregulation of endogenous lamin A/C on chromatin markers. (A) HeLa cells transiently expressing control shRNA or
lamin A/C shRNA vectors (co-expressing GFP) were immunostained with the indicated antibodies. Arrows indicate cells showing depletion of HP1a,
HP1b or lamin A/C. (B) Western blots of lysates (,50,000 cells) from stable clones of control shRNA or lamin A/C shRNA (Cl 27) were probed with the
indicated antibodies. The results shown are representative of three independent experiments. Bar, 10 mm.
doi:10.1371/journal.pone.0047558.g001
Table 1. Expression of HP1 and ZNF genes in lamin A/C
knock-down clones.
Gene Cl 26 Cl 27
HP1a 1.8860.39 1.9260.22
HP1b 1.1960.48 1.3360.22
HP1c 1.3860.38 1.5860.46
ZNF44 2.8960.65** 2.5860.54*
ZNF77 2.0260.28** 2.4060.58*
ZNF85 2.0460.24* 2.1760.67*
ZNF226 1.3560.42 1.2060.23
ZNF266 1.6360.21** 1.5660.44
Values indicate fold-change in real-time PCR transcripts (upregulation)
expressed as mean 6 SD calculated from three independent experiments for
two stable HeLa clones, Cl 26 and 27 expressing lamin A/C shRNA, compared to
a stable clone expressing the control vector.
*p#0.05,
**p#0.01. Cl 26 and 27 showed 2- and 5-fold reduction in lamin A/C transcripts
respectively and ,90% depletion of lamin A/C protein [ref 20].
doi:10.1371/journal.pone.0047558.t001
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mutant of RNF123, though its levels were not altered. We
confirmed that dispersal of emerin required catalytic activity of
RNF123 since N-RNF123 which lacks the catalytic domain, was
unable to disperse emerin (Fig. 3D).
The association of RNF123 with HP1 via the HP1 binding
motif was substantiated by a solid-phase binding assay using
recombinant wild-type and mutant (V313D) N-terminal segment
of RNF123 (residues 59 to 326) expressed as a fusion with bacterial
GST. The GST-N’-RNF123 fusion products migrated at the
correct molecular mass as shown in Fig. 4A. HeLa cell lysates were
incubated with wild-type or mutant GST-N’-RNF123 bound to
glutathione agarose beads and bound proteins were detected by
western blot analysis. Wild-type N’-RNF123 bound to all three
HP1 isoforms whereas binding to mutant N’-RNF123 was much
lower (Fig. 4A). Association of N-RNF123 with HP1 was specific
as binding was not observed with GST alone. These experiments
establish that RNF123 binds directly to HP1 through the PTVLL
binding motif.
In order to validate the role of endogenous RNF123 in HP1
degradation, HeLa cells were transfected with siRNAs to RNF123
as well as control siRNA. Western blot analysis of the lysates
showed that RNF123 specific siRNAs reduced endogenous
RNF123 levels by ,60% compared to control siRNA. This led
to ,30% increase in HP1a and ,60% increase in HP1b but did
not affect HP1c levels (Fig. 4B). The increase in levels of HP1a
and b upon RNF123 depletion indicates a role for endogenous
RNF123 in HP1a and b degradation.
HP1b Mobility is Increased in Presence of Lamin Mutants
The above protein expression data and our earlier study [17]
indicate that HP1a and b but not HP1c are specifically targeted
for proteasomal degradation upon expression of laminopathic
mutations or lamin A/C shRNA in cells. However, our in vitro
Figure 2. Effects of RNF123 on stability of HP1 proteins. (A) HeLa cells expressing GFP-tagged RNF123 were immunostained with the
indicated antibodies and counterstained with DAPI. (B) HeLa cells expressing GFP-tagged RNF123 were treated with 6 mMMG132 and stained. Arrows
indicate cells showing depletion of HP1a or HP1b, or dispersal of emerin; arrowheads indicate cells with restored distribution of markers after MG132
treatment. Bar, 10 mm.
doi:10.1371/journal.pone.0047558.g002
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binding data suggests that all three isoforms bind to the canonical
HP1 motif on RNF123. In order to determine whether there were
any differences in HP1 dynamics in live cells that might lead to
degradation of specific isoforms, we compared the mobilities of
HP1b and HP1c under conditions of lamin misexpression. For this
purpose, fluorescence recovery after photobleaching (FRAP)
experiments were carried out in HeLa cells co-transfected with
GFP-tagged HP1b or HP1c and an RFP-tagged lamin A
construct. A spot of GFP fluorescence in the region of pericentric
heterochromatin near the nuclear periphery was bleached and
fluorescence recovery was measured. FRAP analysis indicated that
there was a significant 2-fold reduction in the half-time of recovery
for GFP-tagged HP1b in the presence of RFP-tagged lamin
mutants G232E and R386K in comparison with wild-type lamin
A, indicating an increase in mobility of HP1b under these
conditions (Fig. 5). This difference was not observed with GFP-
HP1c. The half-time of recovery for GFP-tagged HP1b or c in the
presence of wild-type RFP-tagged lamin A was similar to that
obtained in the absence of ectopic lamin expression. We infer from
this data that the higher mobility of HP1b in the presence of lamin
mutants represents displacement from chromatin, and this is not
observed with HP1c.
Figure 3. Identification of HP1 binding motif at N-terminus of RNF123. (A) HeLa cells transfected with GFP-tagged deletion constructs were
immunostained with antibody to HP1a. Arrows indicate cells showing depletion of HP1a. (B) HeLa cells transfected with GFP-tagged mutant RNF123
(V313D) construct were immunostained with the indicated antibodies. Arrows indicate cells showing dispersal of emerin. All samples were
counterstained with DAPI. Bar, 10 mm. (C) Western blots of lysates from cells expressing deletion constructs, wild-type full length RNF123, mutant
RNF123 or wild-type full length RNF123 after MG132 treatment. (D) HeLa cells transfected with GFP-tagged N-RNF123 were immunostained with
antibody to emerin. (E) Summary of analysis of depletion of HP1a and b with GFP-tagged deletion constructs of RNF123.
doi:10.1371/journal.pone.0047558.g003
RNF123 Mediates HP1 Degradation
PLOS ONE | www.plosone.org 5 October 2012 | Volume 7 | Issue 10 | e47558
Discussion
In the present study, we report that HP1a and b undergo
proteasomal degradation in lamin A/C knock-down cells and
show by ectopic expression, RNAi and binding studies that the
RING finger ubiquitin ligase RNF123 is directly involved in HP1
degradation. Furthermore, GFP-HP1b is destabilized in cells
expressing lamin mutants and depletion of HP1b protein in turn
causes derepression of KRAB zinc finger transcriptional repres-
sors.
Effects of Lamin Misexpression on Heterochromatin
The role of the lamina in organization of chromatin has been
studied extensively and the deleterious effects of laminopathic
mutations or lamin gene disruption on chromatin organization,
nuclear morphology and cellular differentiation have been well
documented [1–5]. In particular, lamin misexpression leads to
abnormalities in heterochromatin organization and HP1 locali-
zation [6–12,21]. We have previously shown that HP1a and b
undergo proteasomal degradation in cells expressing lamino-
pathic mutations and these mutations cause upregulation of
transcripts for two specific ubiquitin ligases, RNF123 and
HECW2, as well as the F-box protein FBXW10 [17]. We
have recently shown that upregulation of these ligase compo-
nents also occurs in lamin A/C knock-down cells, where they
target the DNA damage sensor ATR kinase for degradation
[20]. Our findings imply that upregulation of specific ubiquitin
ligases is a fairly widespread response to defective lamin
assembly due to lamin mutations or knock-down. Our FRAP
experiments show that HP1b is more mobile in the presence of
lamin mutants, suggesting that it is displaced from chromatin
under these conditions. This may lead to its increased
proteasomal degradation. This suggestion is consistent with the
finding that displacement of topoisomerase II binding protein1
from chromatin results in its increased degradation by a HECT
ubiquitin ligase [28].
RNF123 and HP1 Degradation
The RING finger domain ubiquitin ligases function either as
monomeric ligases or as multisubunit ligase complexes. Notably,
the monomeric RING ligases have both a substrate binding
domain and catalytic RING domain for recruitment of the
cognate ubiquitin conjugating enzyme in the same polypeptide,
while multisubunit E3 ligases are comprised of substrate
specifying factors such as F-box proteins and RING domain
proteins that function as a docking platform for ubiquitin
conjugating enzymes [23]. RNF123 is the catalytic subunit of
the KPC ligase, which is comprised of KPC1 and an associated
subunit KPC2, and is required for the degradation of the
cyclin-dependent kinase inhibitor p27Kip1 during the G0 to G1
transition of the cell cycle [24]. In the present study, we have
established a role for RNF123 in the degradation of HP1a and
b by ectopic expression studies, RNAi and mutation analysis.
We have identified a consensus HP1 binding pentapeptide motif
at the N-terminus of RNF123 that upon mutation inhibits the
HP1 binding property of RNF123 and prevents HP1 degrada-
tion. Ubiquitin ligases involved in HP1 degradation have not
been identified earlier; although cullin 4 has been implicated in
heterochromatin assembly [29], its levels are not altered in
laminopathic cells [17]. Our earlier study has shown that HP1
is targeted by FBXW10 [17] and our initial experiments suggest
that HECW2 also degrades HP1a and b (data not shown).
Degradation of HP1 by multiple ligases is not unusual since key
regulatory proteins such as p27Kip1 and ATR kinase are
targeted by several ubiquitin ligases [20,24,30].
The loss of HP1 isoforms can have severe effects on
chromatin function and gene regulation, leading to lethality in
Drosophila and mouse [31,32]. Since HP1b has been reported to
modulate the activity of KRAB-ZNF genes [22], we investigated
the effects of HP1 depletion on the transcript levels of some of
these genes. We observed that depletion of HP1 proteins due to
knock-down of A-type lamins significantly upregulated certain
KRAB-ZNF transcripts. This implies that lamin misexpression
may lead to dysregulation of downstream target genes due to
degradation of chromatin proteins like HP1a and b.
Proteasomal Degradation of Lamin-associated Proteins
Laminopathic mutations or downregulation of lamin A/C leads
to degradation of a number of key regulatory proteins that bind
directly or indirectly via chromatin to lamin A/C. Lamin A/C
knock-down human osteosarcoma cells and embryonic fibroblasts
derived from lamin A/C knock-out mice display enhanced
Figure 4. Specificity of RNF123 for HP1 isoforms. (A) Binding
studies with N’-RNF123 and HP1 proteins. Left panel: Coomassie blue-
stained gel of purified GST, wild-type and mutant GST-N’-RNF123
proteins. Molecular mass markers: phosphorylase b, 97 kD; albumin,
66 kD; ovalbumin, 45 kD; carbonic anhydrase, 30 kD. The asterisk
indicates proteolytic degradation products of GST-N’-RNF123. Right
panel: Western blots of bound proteins from HeLa lysates probed with
antibodies to HP1 proteins. The input lane represents 1% of total lysate
from HeLa cells. (B) Effects of RNF123 siRNA treatment. HeLa were
transfected with siRNAs for RNF123 or a control siRNA and lysates were
probed with the indicated antibodies by western blot analysis.
doi:10.1371/journal.pone.0047558.g004
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proteasomal degradation of pRb [14]. The homozygous nonsense
mutation Y259X in LMNA gene has been reported to cause
mislocalization and subsequent proteasomal degradation of
emerin and nesprin-1a [15], although the ubiquitin ligases
involved have not been identified in both these studies. We have
proposed that the aberrant assembly of the lamina upon lamin
misexpression is likely to lead to disruption of normal interactions
between lamins and chromatin proteins or lamin-binding proteins,
leading to release of bound proteins that are subsequently targeted
for degradation by their cognate ligases. An increase in the
engagement or turnover of these ligases in the nucleus may then
activate their increased expression via a feedback loop [20]. Our
present data on the displacement of HP1b from chromatin in cells
expressing laminopathic mutations is consistent with this model.
Hence inappropriate release of bound proteins due to lamina
disorganization may be a general mechanism leading to their
eventual degradation.
Figure 5. FRAP analysis of GFP-HP1b and GFP-HP1c. (A) Fluorescence images of typical dual-labeled nucleus (RFP-lamin A and GFP-HP1b) and
FRAP processes of GFP-HP1b for the indicated conditions. Circles indicate areas of bleaching where fluorescence recovery was measured. The
illustrated postbleach time-point is 40 sec after bleach. Bar, 5 mm. (B) Graphical presentation of fluorescence recovery as change in relative
fluorescence intensity (RFI) over time. (C) Comparison of half time of recovery of GFP-HP1 in the background of wild-type and mutant RFP-lamin A.
Error bars represent 6 sd with n = 25 to 30 individual cells. ***p#0.001 for mutant cells compared to wild-type lamin A expressing cells.
doi:10.1371/journal.pone.0047558.g005
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Materials and Methods
Plasmid Constructs
Wild-type GFP-lamin A, RFP-lamin A and mutant lamin
mammalian expression constructs have been described earlier
[17,33,34]. For shRNA-mediated knockdown of endogenous
lamin A/C, pcDNA6.2-GW/EmGFP-miR LMNA and control
vector (Life Technologies) were employed. The shRNA targeted
lamin A/C mRNA at nucleotide positions 849–869, correspond-
ing to the sense sequence of GAAGGAGGAACTG-
GACTTCCA. The control vector harboured the scrambled
sequence GAAATGTACTGCGCGTGGAGAC, which does
not target any known vertebrate gene. GFP-HP1b and HP1c
expression vectors were generously provided by Peter Hemmer-
ich (Institute of Molecular Technology, Jena, Germany). An
RNF123 (KPC1) plasmid construct was kindly provided by Bo
Cen (Medical University of South Carolina, USA). GFP-tagged
constructs of RNF123 were made as follows. Full-length
RNF123 was subcloned into XhoI-SmaI digested pEGFP-C1
mammalian expression vector (Clontech). The N-RNF123
construct was made by ligating the HindIII-digested N-terminal
fragment (1.6 kb) of RNF123 to pEGFP-C3, while the N-
terminal deletion mutant of RNF123 (DN-RNF123) was made
by subcloning the 2.6 kb HindIII-SmaI fragment of RNF123
into pEGFP-C1. An EcoRI-SmaI fragment (900 bp) from the
C-terminus of RNF123 which contained only the RING finger
domain was cloned into pEGFP-C2. The C-terminal deletion
construct (DC-RNF123) that does not harbour the RING finger
domain was cloned into XhoI-EcoRI digested pEGFP-C1. The
RNF123 mutant (V313D) was generated by mutating Val-313
to Asp-313 using the QuikChangeTM Site-Directed Mutagenesis
kit (Stratagene Cloning System, La Jolla, CA) according to the
manufacturer’s instructions using a combination of mutagenic
primers 59GCGGGGCCAGCCCACCGACCTCCTCA-
CACTGGCCC39 and 59GGGCCAGTGTGAG-
GAGGTCGGTGGGCTGGCCCCGC 39. N-terminal frag-
ments spanning amino acid residues 59 to 326 of both wild-
type and mutant RNF123 were amplified by PCR (primers
given in Table S1) and cloned into the bacterial expression
vector pGEX-5X3.
Cell Culture, Generation of Stable Cell Lines, RNAi and
Drug Treatment
HeLa cells were grown in DMEM supplemented with 10%
FBS at 37uC in a humidified atmosphere containing 5% CO2
[17]. Plasmid constructs were transiently transfected into HeLa
cells for 24 h using Lipofectamine 2000 (Invitrogen) by standard
protocols. For treatment with proteasomal inhibitors, cells were
incubated with 6 mM MG132 (Calbiochem) for 18 h starting at
6 h after transfection of plasmids. Stable lines expressing control
or lamin A/C shRNA plasmids were generated by blasticidin
selection as described [20]. For downregulation of RNF123
using RNAi, RNF123 mRNA was targeted using a pool of
siRNAs (Bioserve Technology, Hyderabad, India) having the
sequences 59UCAACAGCGUCCUCAAUCA39, 59CCAC-
CAUCGUGUCUGUAGA39 and 59GUGGCCAUCAACAG-
CUACAGU39 corresponding to positions 3215–3233, 4004–
4022 and 2731–2751 respectively. The sequence 59UUCUCC-
GAACGUGUCACGU39, predicted not to target any known
mammalian mRNA sequence, was used as a negative control. A
10 nM solution of siRNAs was transiently transfected into HeLa
cells for 36 h using Lipofectamine 2000.
RNA Isolation and Quantitative Real-time PCR Analysis
Total RNA was extracted from HeLa cells stably expressing
the shRNA constructs against lamin A/C or control vector and
1 mg of RNA was reverse transcribed using Superscript II
reverse transcriptase kit (Invitrogen) as per the manufacturer’s
instructions. Amplification of PCR products was quantitated
using SyBR green dye (ABI) and monitored on an ABI prism
7900 HT sequence detection system. Melting curve analysis was
done for each amplicon. The DDCt method was used for
quantitation using HPRT1 (hypoxanthine phosphoribosyl trans-
ferase 1) as endogenous control. The analysis for each gene was
done in triplicate and three independent biological replicates
were carried out. Gene expression in lamin A/C knock-down
stable clones was expressed as fold change in comparison with
HeLa cells stably expressing control shRNA vector. The gene
specific primers used for real-time PCR analysis are given in
Table S1.
Antibodies and Western Blot Analysis
A polyclonal antibody to lamin A/C and a mouse mAb to
tubulin were from Santa Cruz Biotechnology. Mouse mAbs to
HP1a, b and c were obtained from Millipore. Polyclonal
antibodies to GFP, GAPDH and HP1a, b and c were from
Abcam. A mouse mAb to emerin (clone 4G5) was obtained from
Novocastra Laboratories and a mouse mAb to RNF123 was from
Sigma-Aldrich Corporation. For western blot analysis, cells were
lysed in Laemmli’s sample buffer, boiled and electrophoresed
through SDS-10% polyacrylamide gels. Gels were electroblotted
onto PVDF membrane filters and blocked for 1 h at ambient
temperature in 5% BLOTTO in Tris-buffered saline containing
0.1% Tween-20. Blots were incubated with primary antibody for
2 h, followed by peroxidase conjugated-secondary antibody in
Tris-buffered saline containing 0.1% Tween-20 for 1 h. Antibody
binding was analyzed using a chemiluminescence kit from Roche
Applied Science and scanned blots were quantitated with ImageJ
software.
Solid-phase Binding Assays
Recombinant GST-N’-RNF123 clones and pGEX-5X3 vector
were expressed in E. coli BL21(DE3)-pLys(S) by induction with
1 mM IPTG for 3 h at 37uC. Cells were lysed in 100 mM
EDTA, 1% Triton X-100, 10 mM sodium phosphate buffer,
pH 7.2, 150 mM NaCl, 1 mM PMSF, 0.5 mM DTT and 2%
protease inhibitors. The supernatants containing the expressed
proteins were incubated with glutathione agarose beads for 2–
3 h at 4uC, centrifuged and washed with lysis buffer. HeLa cells
were lysed in buffer containing 50 mM Tris-Cl pH 7.5,
150 mM NaCl, 10% glycerol, 0.5% NP-40, 2 mM EDTA,
2 mM EGTA, 2 mM PMSF, 2 mM NaF, 2 mM Na3VO4 and
protease inhibitors, and the supernatant was pre-cleared with
glutathione agarose beads. The pre-cleared supernatant was
incubated with equal quantities of beads bound to either GST
or GST-fusion proteins for 12 h at 4uC, centrifuged and washed
with lysis buffer, separated by SDS-PAGE and analyzed by
western blotting.
Immunofluorescence Microscopy
HeLa cells were fixed with 4% formaldehyde in phosphate-
buffered saline (PBS) for 10 min followed by treatment with
0.5% (v/v) Triton X-100 for 6 min at room temperature. Cells
were subsequently incubated with 0.5% gelatin in PBS for 1 h
and then incubated with primary antibody for 1 h followed by
Cy3-conjugated secondary antibody for 1 h. Samples were
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mounted in Vectashield (Vector Laboratories) containing 1 mg/
ml DAPI. Fluorescence microscopy of the immunostained cells
was performed using a LSM510 META/NLO confocal
microscope. Images were analyzed with LSM510 META
software and assembled using Photoshop CS3.
Live Cell Microscopy
HeLa cells transiently co-transfected with RFP-tagged lamin A
constructs and GFP-tagged HP1b or HP1c [35] were seeded on a
LabTekII chamber slide and grown for 24 h. Fluorescence
recovery after photobleaching (FRAP) experiments were per-
formed on an LSM510 META/NLO inverted confocal micro-
scope with a 63x/1.20 Wkorr planapochromat water objective
lens as described [36]. A GFP-HP1 spot of 1 mm in radius was
bleached for 0.33 sec using the 900 nm laser line at 80% laser
power, and a series of images was acquired at 304-msec intervals
immediately after bleaching. RFP was not bleached under these
conditions. Recovery of fluorescence was observed for 50 sec. All
intensities were background subtracted for calculation of FRAP
curves, which represented an average of 25–30 individual cells
bleached under identical conditions in at least three independent
experiments. The relative fluorescence intensity (RFI) at each time
point was calculated as described by Phair and Misteli [37], using
the equation RFI= (It/Tt)/(I0/T0) where I0 and It are the average
intensity of the region of interest before and after bleaching at time
t, and T0 and Tt are the total intensity in the nucleus before and
after bleaching at time t. Non-linear curve fitting was carried out
using MS-Excel. In control experiments in which formaldehyde-
fixed cells were analyzed, no recovery of fluorescence was
observed.
Supporting Information
Table S1 List of PCR primers.
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